"SKiN Health offers Dermatological, Cosmetic Dermatology and Research services at two locations in Peterborough and Cobourg. The SKiN Centre for Dermatology offers a comprehensive range of diagnostic treatment and services for skin, hair and nails. Our team of certified medical professionals uses up-to-date equipment and has access to the latest research in the field. We are dedicated to providing the best experience in dermatological care. Our Research department is participating in various research trials relating to a number of skin conditions. Please visit our website for more information about our research trials."

During the past decade, SKiN Centre for Dermatology conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 46 clinical trials were completed, i.e. on average, 97.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 34 clinical trials were completed. i.e. 226.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SKiN Centre for Dermatology" #1 sponsor was "Pfizer" with 20 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "LEO Pharma" with 7 trials sponsored, "Amgen" with 6 trials sponsored and "Incyte Corporation" with 6 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SKiN Centre for Dermatology" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "SKiN Centre for Dermatology" are "Psoriasis" (18 trials), "Atopic Dermatitis" (11 trials), "Plaque Psoriasis" (9 trials), "Alopecia Areata" (5 trials) and "Dermatitis, Atopic" (5 trials). Many other conditions were trialed in "SKiN Centre for Dermatology" in a lesser frequency.

Most popular intervention types in "SKiN Centre for Dermatology" are "Drug" (58 trials), "Other" (8 trials), "Biological" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Apremilast" (5 trials), "Adalimumab" (3 trials), "Guselkumab" (3 trials) and "PF-04965842 100 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "SKiN Centre for Dermatology" are 61 trials for "All" genders.

Currently, there are NaN active trials in "SKiN Centre for Dermatology". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in SKiN Centre for Dermatology, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in SKiN Centre for Dermatology, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".